Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Mono Pharmacare

₹44.6 0 | 0%

Market Cap ₹79 Cr.

Stock P/E

P/B 4.5

Current Price ₹44.6

Book Value ₹ 10

Face Value 10

52W High ₹75

Dividend Yield 0%

52W Low ₹ 28.1

Mono Pharmacare Research see more...

Overview Inc. Year: 2022Industry: Trading

Mono Pharmacare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Mono Pharmacare Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Mono Pharmacare Profit & Loss

#(Fig in Cr.) Mar 2023 TTM
Net Sales 33
Other Income 0
Total Income 33
Total Expenditure 31
Operating Profit 2
Interest 1
Depreciation 0
Exceptional Income / Expenses 0
Profit Before Tax 1
Provision for Tax 0
Profit After Tax 1
Adjustments -0
Profit After Adjustments 1
Adjusted Earnings Per Share 0.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 7% 7% 7% 7%
ROCE Average 4% 4% 4% 4%

Mono Pharmacare Balance Sheet

#(Fig in Cr.) Mar 2023
Shareholder's Funds 14
Minority's Interest 0
Borrowings 15
Other Non-Current Liabilities -0
Total Current Liabilities 34
Total Liabilities 63
Fixed Assets 1
Other Non-Current Assets 1
Total Current Assets 61
Total Assets 63

Mono Pharmacare Cash Flow

#(Fig in Cr.) Mar 2023
Opening Cash & Cash Equivalents 0
Cash Flow from Operating Activities -40
Cash Flow from Investing Activities -1
Cash Flow from Financing Activities 41
Net Cash Inflow / Outflow 0
Closing Cash & Cash Equivalent 0

Mono Pharmacare Ratios

# Mar 2023
Earnings Per Share (Rs) 0.76
CEPS(Rs) 0.81
DPS(Rs) 0
Book NAV/Share(Rs) 11.06
Core EBITDA Margin(%) 6.77
EBIT Margin(%) 6.8
Pre Tax Margin(%) 3.98
PAT Margin (%) 2.86
Cash Profit Margin (%) 3.01
ROA(%) 1.51
ROE(%) 6.91
ROCE(%) 4.19
Receivable days 241.26
Inventory Days 360.58
Payable days 86.6
PER(x) 0
Price/Book(x) 0
Dividend Yield(%) 0
EV/Net Sales(x) 1.57
EV/Core EBITDA(x) 22.56
Net Sales Growth(%) 0
EBIT Growth(%) 0
PAT Growth(%) 0
EPS Growth(%) 0
Debt/Equity(x) 2.92
Current Ratio(x) 1.82
Quick Ratio(x) 0.85
Interest Cover(x) 2.42
Total Debt/Mcap(x) 0

Mono Pharmacare Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024
Promoter 56.72 56.72 56.72
FII 0 0 0
DII 0 0 0
Public 43.28 43.28 43.28
Others 0 0 0
Total 100 100 100

Pros

  • Debtor days have improved from 86.6 to days.
  • Company has reduced debt.

Cons

  • Company has a low return on equity of 7% over the last 3 years.
  • Stock is trading at 4.5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Mono Pharmacare News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....